---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-033859"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2026-05-12T11:04:29+00:00"
generated_at: "2026-05-12T11:05:26.175530+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ovid Q1 net loss $17M; raises $60M PIPE; dosed first OV4071 Phase 1; OV329 Phase 2 planned

## Summary
- Q1 2026 net loss of $17.0M ($0.12/share) vs $10.2M loss ($0.14) in Q1 2025.
- Cash $165.6M as of Mar 31, 2026; plus $27.3M in April from warrant exercises; runway into 2029.
- Dosed first healthy volunteer in Phase 1 study of OV4071, oral KCC2 direct activator, for psychosis.
- OV329 shows favorable safety/PK up to 9 mg; Phase 2 for focal onset seizures and TSC/infantile spasms planned.
- Raised $60.0M gross from March 2026 PIPE and $53.9M from Series A warrant exercises (Oct 2025 PIPE).

## SEC filing metadata
- accession: 0001628280-26-033859
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2026-05-12T11:04:29+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000162828026033859/0001628280-26-033859-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000162828026033859/ovid-20260512.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-033859
- JSON: https://secwatch.observer/filing/0001628280-26-033859.json
- Plain text: https://secwatch.observer/filing/0001628280-26-033859.txt

## Key facts
- Earnings Releases
  Ovid Therapeutics Inc. reported financial results for first quarter ended March 31, 2026.
  - Period: first quarter ended March 31, 2026
  - Result: reported results
  source text: On May 12, 2026, Ovid Therapeutics Inc. (the “Company”) issued a press release announcing business updates and first quarter 2026 financial results.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636651/000162828026033859/0001628280-26-033859-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.